Clostridioides difficile
AssigneeImperial College of Science, Technology and Medicine
InventorsJulian Marchesi, Julie Mcdonald, Benjamin Mullish
Life of this patent
Estimating the term…
Abstract
The invention relates to Clostridioides difficile, and in particular to compounds, polypeptides and mixtures for the treatment of C. difficile infections. The invention also relates to nucleic acids, vectors comprising these nucleic acids and microorganisms for the treatment of C. difficile infections, and to methods of identifying and matching faecal microbiota transplant (FMT) donors to FMT recipients.
Claims7
A method of treating, preventing or ameliorating a Clostridioides difficile infection by selectively inhibiting the growth of Clostridioides difficile, the method comprising administering, to a subject in need thereof, a therapeutically effective amount of a compound of Formula (I):
- wherein R1 is a C4 to C6 alkyl or fluorinated alkyl;
- and
- R2 is hydrogen or a C1 to C4 alkyl or halogenated alkyl, and the C1 to C4 alkyl or halogenated alkyl is optionally substituted with between 1 and 5 substituents, wherein each substituent has the formula:
- wherein each R3 is independently a C2 to C10 alkyl or halogenated alkyl;
- or a pharmaceutically acceptable salt of the compound of Formula I, solvate of the compound of Formula I, tautomeric form of the compound of Formula I or polymorphic form of the compound of Formula I.
Dependencies are inferred from the claim text.